IL2RA and type 1 diabetes mellitus: The results revealed an OR of 0.22 (95% CI 0.17, 0.27) for type 1 diabetes risk (p=5.3 × 10−43) per SD increase in genetically proxied IL2RA expression, an OR of 1.98 (95% CI 1.48, 2.65) per SD increase in genetically proxied IL6R expression (p=5.2 × 10−6) and an OR of 1.90 (95% CI 1.45, 2.48) per SD increase in genetically proxied IL6ST expression (p=2.6 × 10−6; Table 3).